Re: TD Zenith Capital Corp | Grey Market : ZENI.P
in response to
by
posted on
Oct 20, 2020 08:42AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Does anyone know what business ZENI.P is into?
0.19 CAD 0.00 (0.00%)